(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DERIVADOS DE EXATECAN E CONJUGADOS ANTICORPO-FÁRMACO DESTES

Em AnáliseInvention PatentPCT · US2022028193

Application data

Number

112023023276

Type

Invention Patent

Filing

05/06/2022

Publication

01/30/2024

PCT

US2022028193

Progress at the INPI

  1. Filing05/06/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 05/06/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 01/30/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ALX ONCOLOGY INC.

US

See this company's full portfolio

Inventors

J. W. (pessoa física)

US

J. P. (pessoa física)

US

M. V. (pessoa física)

US

P. S. (pessoa física)

US

Technical data

Priority claims

US

63/185,736 · 05/07/2021

US

63/248,705 · 09/27/2021

US

63/321,187 · 03/18/2022

Abstract

DERIVADOS DE EXATECAN E CONJUGADOS ANTICORPO-FÁRMACO DESTES.São revelados nesse relatório descritivo, em parte, novos derivados de exatecan com novos vinculadores químicos que incluem porções cliváveis por catepsina B, e conjugados a anticorpos de direcionamento.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

01/30/2024

RPI 2769

Alteração de dados cadastrais

#1.1

11/14/2023

RPI 2758

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.